Day 3 embryo assessment does not provide a reliable prediction for blastocyst formation and designation: a retrospective cohort study.

blastocyst cleavage day 3 day 5 in-vitro fertilisation

Journal

Zygote (Cambridge, England)
ISSN: 1469-8730
Titre abrégé: Zygote
Pays: England
ID NLM: 9309124

Informations de publication

Date de publication:
23 Sep 2024
Historique:
medline: 23 9 2024
pubmed: 23 9 2024
entrez: 23 9 2024
Statut: aheadofprint

Résumé

Although many Fertility Centers have adopted day 5 or 6 embryo transfer policy, yet, 30% of embryo transfers in the US are performed on day 3. This is mainly due to concerns related to longer embryo culture effect and higher rates of embryo transfer cancellation on day 5, with no effect on cumulative pregnancy rate. We conducted a retrospective cohort study comparing individual embryo transfer order rank, best embryo for fresh transfer and intention to freeze, of day-3 and day-5 embryos based on their morphology score. Day-3 embryos of each patient were ranked by embryologists for the order of transfer and intention to freeze, based on morphological score, blinded to actual blastulation outcome. The corresponding blastocysts were similarly ranked for the order of transfer and vitrification intention. Ranking was compared to test the predictive value of day-3 morphological assessment. Sixty patients with 784 day-3 embryos were included. There was only a moderate positive significant correlation between ranks on day-3 and ranks on day-5 [

Identifiants

pubmed: 39308361
pii: S0967199424000248
doi: 10.1017/S0967199424000248
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-7

Auteurs

Michal Youngster (M)

IVF Unit, Department of Obstetrics & Gynaecology, Shamir Medical Center, Zerifin, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Maria Shvaikovsky (M)

Department of Obstetrics & Gynaecology, Mayanei Hayeshua Medical Center, Bnei Brak, Israel.

Sarit Avraham (S)

IVF Unit, Department of Obstetrics & Gynaecology, Shamir Medical Center, Zerifin, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Dvora Strassburger (D)

IVF Unit, Department of Obstetrics & Gynaecology, Shamir Medical Center, Zerifin, Israel.

Esti Kasterstein (E)

IVF Unit, Department of Obstetrics & Gynaecology, Shamir Medical Center, Zerifin, Israel.

Bila Maslansky (B)

IVF Unit, Department of Obstetrics & Gynaecology, Shamir Medical Center, Zerifin, Israel.

Itai Gat (I)

IVF Unit, Department of Obstetrics & Gynaecology, Shamir Medical Center, Zerifin, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Sperm Bank & Andrology Unit, Shamir Medical Center, Zerifin, Israel.

Gil Yerushalmi (G)

IVF Unit, Department of Obstetrics & Gynaecology, Shamir Medical Center, Zerifin, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Yariv Gidoni (Y)

IVF Unit, Department of Obstetrics & Gynaecology, Shamir Medical Center, Zerifin, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Ariel Hourvitz (A)

IVF Unit, Department of Obstetrics & Gynaecology, Shamir Medical Center, Zerifin, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Alon Kedem (A)

IVF Unit, Department of Obstetrics & Gynaecology, Shamir Medical Center, Zerifin, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Classifications MeSH